A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

PHASE3RecruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

May 30, 2023

Primary Completion Date

December 30, 2025

Study Completion Date

March 31, 2026

Conditions
Diabetic Foot UlcerFoot UlcerDiabetes MellitusWound
Interventions
DRUG

ENERGI-F703 GEL

Standard of care and ENERGI-F703 GEL are applied for the treatment of diabetic foot ulcers.

DRUG

ENERGI-F703 matched vehicle

Standard of care and ENERGI-F703 matched vehicle are applied for treatment of diabetic foot ulcers.

Trial Locations (24)

31904

RECRUITING

IACT Health, Columbus

33135

RECRUITING

A and D Doctor Center, Miami

33155

RECRUITING

Bioclinical Research, Miami

33165

RECRUITING

Reliant Medical Research, Miami

33176

RECRUITING

New Horizons Research, Palmetto Bay

38305

RECRUITING

The Jackson Clinic PA, Jackson

77095

RECRUITING

Mt. Olympus Medical Research, Houston

84107

RECRUITING

Wasatch Clinical Research, Salt Lake City

33174-3201

RECRUITING

Advanced Medical Research Institute, Miami

24153-6404

RECRUITING

Salem Veterans Affairs Medical Center VAMC, Salem

Unknown

RECRUITING

Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City

RECRUITING

Kaohsiung Medical University Hospital, Kaohsiung City

RECRUITING

China Medical University Hospital, Taichung

RECRUITING

Kung Tien General Hospital, Taichung

RECRUITING

Taichung Veterans General Hospital, Taichung

RECRUITING

Chi Mei Medical Center, Tainan City

RECRUITING

National Cheng Kung University Hospital, Tainan City

RECRUITING

Cathay General Hospital, Taipei

RECRUITING

MacKay Memorial Hospital, Taipei

RECRUITING

National Taiwan University Hospital, Taipei

RECRUITING

Shin Kong Wu Ho Su Memorial Hospital, Taipei

RECRUITING

Taipei Veterans General Hospital, Taipei

RECRUITING

Tri-Service General Hospital, Taipei

RECRUITING

Linkou Chang Gung Memorial Hospital, Taoyuan District

All Listed Sponsors
lead

Energenesis Biomedical Co., Ltd.

INDUSTRY